Glyconutrients

GlycoCheck is a leading provider of imaging solutions based on an innovative measurement system of the Glycocalyx layer. GlycoCheck solutions facilitate the accurate, reliable and non-invasive selection, detection & monitoring of patients in primary care, intensive care, cardiology and internal medicine.

Non-invasive GlycoCheck testing technology quantifies vessel density, red blood cell concentration, blood flow and glycocalyx function.

In this series you will gain the clearest explanation you will ever hear to help you understand how to completely reverse Type 2 Diabetes, how to understand your lipid profile LDL, HDL and VLDL, and how to reverse atherosclerotic coronary artery disease naturally. In addition, you will learn the extremely harmful effects of sugar, and you will understand how the structure lining the arteries plays a critical role in health and arterial disease. 1. Reversing Diabetes 2. Lowering Cholesterol Naturally 3. Fructose Poisoning of the Liver 4. The Glycocalyx

You may not know it, but like so many people, your body could be on a perilous journey down a spiral of troubling conditions and silent killers. Healthy organs are nourished with vital nutrients and oxygen, while waste and carbon dioxide are removed with every heartbeat—if the microscopic capillaries that feed all of the cells in your body are thriving. But that process can be severely impaired—and life-supporting capillaries can even disappear if their protective gel-like lining—the glycocalyx—is damaged. Let’s see how easily—and silently—this happens. Over time, aging, poor diet, lack of exercise, genetics, stress, smoking—and even conditions such as diabetes and high blood pressure—combined with other risk factors—can slowly, but surely, break down the glycocalyx. Damaged microvessels—your capillaries, for the most part—become leaky, lose function, and their numbers decrease. So, the vital delivery of nutrients, hormones, and oxygen is compromised—as is the removal of waste and carbon dioxide. The downward spiral continues. Deprived of this critical, regenerative exchange, organ starvation begins, weakening vital processes in the heart, kidneys, lungs, and brain. Diseases and conditions can set in, including heart and kidney disease, lung disease, stroke and dementia, septic shock, inflammatory disorders—and even cancer metastasis. With so many areas of the body and its functions under attack, complications develop. Critical organs fail—one after the next. Finally, the body’s ability to keep up with the assault fails, and can lead to death. Fortunately, this spiral of breakdowns can be identified in the early stages so you can make changes before it’s too late. Learn more by clicking the button below or visiting https://microvascular.com/.

A thick endothelial surface coat consisting of the glycocalyx and associated plasma proteins has been hypothesized to reduce functional capillary volume available for flowing plasma macromolecules an

The cerebral microcirculation and its glycocalyx, a matrix coating the luminal endothelium, are key regulators of capillary permeability and cerebral …

13 early warning signs all point to a single hidden problem. Your microvascular system may be breaking down, and your organs could be slowly starving and you don’t even know it. These early warning signs may be caused by a problem hidden in the smallest blood vessels in your body—your microscopic capillaries. Learn more at https://microvascular.com/.

Our Microvascular supplement improves Glycocalyx Health effectively. Endocalyx™ has been clinically shown to maintain blood flow circulation. Shop online now!

This review aims at presenting state-of-the-art knowledge on the composition and functions of the endothelial glycocalyx. The endothelial glycocalyx is a network of membrane-bound proteoglycans and glycoproteins, covering the endothelium luminally. Both ...

Could you have imagined that one of the most essential elements for your good health lies in a vast protective gel lining of all of your capillaries that touches each of your trillions of cells … and most likely, you’ve never even heard about it. Come with me as we travel inside your vascular system and flow along with your blood. Every cell of your body is nourished by the blood that travels through the capillaries that make up 99% of your circulatory system-from head to toe. Placed end-to-end, scientists estimate they would extend 60,000 miles, enough to go around the earth two and a half times. With every heartbeat, vital nutrients and oxygen are delivered and waste is removed from each cell. This essential process breaks down with aging, poor diet, lack of exercise, genetics, stress and smoking. New medical science has revealed the importance of a transparent micro-thin gel-like lining in your blood vessels that protects your entire circulatory system. In the past, blood vessels were thought to be simple hollow tubes. But with today’s high resolution video microscopes, a discovery reveals that the entire circulatory system is coated with a gel like lining that protects the inside walls of the arteries, veins and capillaries. This protective gel-like lining of the capillaries and all other blood vessels is called the glycocalyx. Its integrity is essential to the healthy function of all the cells, organs and body systems. The glycocalyx keeps your body healthy in three critical ways. First, it functions as the natural trigger that stimulates the production of nitric oxide. Nitric oxide is vital in controlling blood flow and blood pressure. The glycocalyx stores anti-oxidants and, working together with nitric oxide, both increase blood flow, on demand, when organs call for it. For example, when you’re walking upstairs. Or even when your brain is working through a difficult problem. Bottom line: your body needs a thick and healthy glycocalyx to efficiently regulate blood flow. Second, a healthy glycocalyx allows your body to engage more of the available capillaries of the microvascular system when blood flow increases. This is critical to regulate the supply of nutrients and oxygen, and the removal of waste and carbon dioxide, according to the body’s level of activity, such as when you exercise. Bottom line: While blood flow control is important, the glycocalyx allows your body to engage more capillaries when organs demand nourishment and waste removal. Third, capillaries are much more than simple hollow tubes. In fact, their inner surface is coated with the non-stick glycocalyx that prevents loss of capillaries through fluid leakage, blood clotting and inflammation. This coating prevents sticking when you don’t need it, and it keeps blood clotting and inflammation under control. For example, when your body’s healthy, it can repair a simple cut or fight an infection. Bottom line: a healthy glycocalyx not only engages more capillaries when blood flow goes up, but it also protects the capillary network and even the entire vascular system from deterioration and loss. Ongoing clinical research from more than 50 studies confirms that a compromised glycocalyx and a damaged microvascular system are linked to organ starvation. Early warning signs of organ starvation include cold hands and feet, leg cramps, skin problems, hair thinning, fatigue, lack of focus, memory loss, certain eye problems, hearing loss, severe PMS, erectile dysfunction, high blood pressure, and even type 2 diabetes. Emerging research is beginning to show that it’s not too late to slow down, or even reverse, the breakdown of the protective properties of the glycocalyx. More at https://microvascular.com/

Sugar-protein glycocalyx coats healthy endothelium, but its ultrastructure is not well described. Our aim was to determine the three-dimensional ultrastructure of capillary endothelial glycocalyx in the heart, kidney, and liver, where capillaries are, ...

Background Glucosamine hydrochloride, a natural biopolymer present in the daily diet, has various biological activities including antitumour properties and protective effects against pathogens. Early studies showed that daily administration of a derivative of glucosamine induced proliferation of leukemia cells and prolonged overall survival in mice; importantly, no toxicity was associated with the glucosamine treatment. However, the potential mechanism of the antitumour effect is unknown. This study aimed to investigate the inhibitory mechanism and effect of glucosamine on human gastric carcinoma cells in vitro. Methods Gastric carcinoma MKN-45 cells were exposed to 0, 100, 500 and 1000 µg/mL glucosamine hydrochloride for 72 hours, and then the viability and proliferation of gastric carcinoma cells in vitro was measured using the MTT (3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide) assay. Quantitative gene expression of MMP-2 and -3 was determined by real-time polymerase chain reaction. Protein level was analyzed using an enzyme-linked immunosorbent assay (ELISA). Results Glucosamine hydrochloride has a significant inhibitory antitumour effect on MKN-45 cells in vitro. The cell viability of MKN-45 cells treated with different concentrations of glucosamine hydrochloride rose continuously from 24 to 72 hours compared with the untreated control. MKN-45 cells were inhibited by 54% by 500 µg/mL glucosamine hydrochloride and by 85% by 1000 µg/mL glucosamine hydrochloride. Administration of 500 µg/mL glucosamine hydrochloride resulted in a significant decrease in MMP-2 and MMP-3 expression of about 79% and 70%, respectively, in MKN-45 cells. Conclusions In this study, we showed that the antitumour activity of glucosamine hydrochloride significantly suppresses MKN-45 cells in vitro. This effect was shown by inhibitory gene expression of MMP-2 and -3. Acknowledgments This research was financially supported by Zhuhai College of Jilin University.

Background: Osteoarthritis (OA) is a degenerative disease with complex underling mechanisms 1–3. The interactions among several factors make the study of the disease very complex and often lead to different treatment, i.e. surgical or conservative, decisions for subjects clinically and radiographically similar. Recent explorations performed at the body level pointed out that macro-factors, like overweight or gait, can influence the development of the disease 4. The number of related factors is high, and they are very likely to interact with each other. However, the literature lacks randomized and balanced studies to verify such effects of multiple factors 5. Objectives: The aim of this work was to develop a multifactorial analysis to explore whether and how gait functionality and dynamics can be related to treatment decision. Methods: A multifactorial analysis of gait dynamics in OA subjects was developed. 81 OA subjects, graded 2-3 in KL, were selected based on 4 clinical factors: Gender (male – female), Age (60-67 – 68-75), BMI (25–29.9 – 30+) and Treatment (total knee replacement (TKR) – conservative treatment). Gait analysis was performed using 8 cameras BTS Smart-DX 700, 1.5 Mpixels 250 fps and 2 force plates BTS P-6000 500 Hz sampling (BTS S.p.A., Milan, Italy). Helen Hayes marker protocol with medial markers was used for the study. Each volunteer was asked to perform a minimum of 5 valid gait sequences. Functionality and dynamics parameters were measured. Functionality : Velocity of gait and the time needed to perform a gait cycle were computed. Dynamics: The reaction forces and torques at the ankles, knees and hips were computed through inverse dynamic analyses. Analysis of variance was performed for the four factors described among the functionality and dynamics parameters. Results: The multifactorial analysis showed that functionality values are more subjective to the studied factors than the dynamics ones. Functionality seems to be directly related to the clinical treatment. Patients who selected TKR needed more time to make a step, spent more time in double stand position and walked slower (p

Osteoarthritis is a chronic degenerative joint disease causing pain and disability. Glucosamine sulphate is a well known oral supplement for its treatment. The present pioneering study provides an overview of the accentuated transdermal delivery of glucosamine sulphate through the optimized gel formulation w

Rheumatoid arthritis (RA) is an autoimmune disorder that affects the joint synovium. Anserine is a functional dipeptide containing methylhistidine and β-alanine, and is present in the brain and skeletal muscle of birds and mammals. Glucosamine is an amino sugar used in the synthesis of glycosylated proteins and lipids. We evaluated the effects of anserine and glucosamine on RA. Rats were assigned into the control group, RA group, anserine group (1 mg/kg), glucosamine group (200 mg/kg), or anserine plus glucosamine group (anserine, 1 mg/kg + glucosamine, 200 mg/kg). Treatment was continued for 45 consecutive days and was administered orally. The serum levels of catalase, glutathione peroxidase (Gpx), superoxide dismutase (SOD), reduced glutathione (GSH), lipid peroxidation, uric acid, nitric oxide, ceruloplasmin, zinc, copper, prostaglandin E2 (PGE2), matrix metalloproteinase (MMP)-3, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 were assayed. The mRNA and protein levels of nuclear factor (NF)-κB and inducible nitric oxide synthase (iNOS) in synovial tissue were also determined. Anserine plus glucosamine significantly increased the catalase, SOD, Gpx, GSH, and zinc levels compared to the control, anserine, and glucosamine groups. Also, anserine plus glucosamine significantly reduced the PGE2, MMP-3, TNF-α, IL-1β, and IL-6 levels compared to the control, anserine, and glucosamine groups. Furthermore, anserine plus glucosamine significantly reduced the mRNA and protein levels of NF-κB and iNOS compared to the control, anserine, and glucosamine groups. Therefore, supplementation of anserine plus glucosamine shows therapeutic potential for RA.

Lung cancer is the most common cause of cancer‑associated mortality worldwide, and glucosamine has the potential to exhibit antitumor activity. To reveal its anti‑lung cancer mechanism, the present study investigated the effect of glucosamine on the transcriptional activity of forkhead box O (FOXO)1 …

Background Renal cell carcinoma (RCC) is one of the most common types of cancer in urological system worldwide. Recently, the anticancer role of Glucosamine has been studied in many types of cancer. The aim of this study was to investigate the effects of Glucosamine on RCC. Methods The effects of Glucosamine on RCC cell proliferation and apoptosis were investigated by MTT assay and Annexin V-FITC Apoptosis assay, respectively in vitro. Cell cycle was detected by flow cytometry after treatment with Glucosamine. Protein levels of several cell cycle associated markers were examined by Western Blot. Results Our data showed that Glucosamine significantly inhibited the proliferation of renal cancer 786-O and Caki-1 cells in a dose-dependent manner. Besides, Glucosamine treatment resulted in cell cycle arrest at G0/G1 phase in both cell lines. Meanwhile, the expression of several regulators that contribute to G1/S phased transition, such as Cyclin D1, CDK4 and CDK6, were significantly down-regulated with the up-regulation of cell cycle inhibitors, p21 and p53, after treatment with glucosamine. However, the apoptosis rate of RCC cells was down-regulated when treatment with Glucosamine at 1 mM and 5 mM, while up-regulated at 10 mM. Conclusions Our findings indicated that Glucosamine inhibited the proliferation of RCC cells by promoting cell cycle arrest at G0/G1 phase, but not promoting apoptosis. The present results suggested that Glucosamine might be a potential therapeutic agent in RCC treatment in the future.

Glucosamine (GlcN), also known as aminosaccharide, is an important functional monosaccharide and the first amino monosaccharide to be identified as a hydroxyl group of glucose substituted by amino ...

Read it now on PracticeUpdate.com

Objective To prospectively assess the association of habitual glucosamine use with risk of cardiovascular disease (CVD) events. Design Prospective cohort study. Setting UK Biobank. Participants 466 039 participants without CVD at baseline who completed a questionnaire on supplement use, which included glucosamine. These participants were enrolled from 2006 to 2010 and were followed up to 2016. Main outcome measures Incident CVD events, including CVD death, coronary heart disease, and stroke. Results During a median follow-up of seven years, there were 10 204 incident CVD events, 3060 CVD deaths, 5745 coronary heart disease events, and 3263 stroke events. After adjustment for age, sex, body mass index, race, lifestyle factors, dietary intakes, drug use, and other supplement use, glucosamine use was associated with a significantly lower risk of total CVD events (hazard ratio 0.85, 95% confidence interval 0.80 to 0.90), CVD death (0.78, 0.70 to 0.87), coronary heart disease (0.82, 0.76 to 0.88), and stroke (0.91, 0.83 to 1.00). Conclusion Habitual use of glucosamine supplement to relieve osteoarthritis pain might also be related to lower risks of CVD events.